147 related articles for article (PubMed ID: 15135265)
1. Prognostic value of plasma interleukin-6 concentrations and the -174 G > C and -572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis.
Bennermo M; Held C; Green F; Strandberg LE; Ericsson CG; Hansson LO; Watkins H; Hamsten A; Tornvall P
Atherosclerosis; 2004 May; 174(1):157-63. PubMed ID: 15135265
[TBL] [Abstract][Full Text] [Related]
2. In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis.
Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Gemitzis K; Kalampalika D; Vayona MA; Pidonia I; Parharidis G; Louridas G
Angiology; 2006; 57(3):283-93. PubMed ID: 16703188
[TBL] [Abstract][Full Text] [Related]
3. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
[TBL] [Abstract][Full Text] [Related]
4. The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients.
Antonicelli R; Olivieri F; Bonafè M; Cavallone L; Spazzafumo L; Marchegiani F; Cardelli M; Recanatini A; Testarmata P; Boemi M; Parati G; Franceschi C
Int J Cardiol; 2005 Sep; 103(3):266-71. PubMed ID: 16098388
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of anti and pro-inflammatory cytokine genes and their promoter polymorphism with ST-elevation of myocardial infarction.
Biswas S; Ghoshal PK; Mandal N
Gene; 2014 Jul; 544(2):145-51. PubMed ID: 24786212
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men.
Chiappelli M; Tampieri C; Tumini E; Porcellini E; Caldarera CM; Nanni S; Branzi A; Lio D; Caruso M; Hoffmann E; Caruso C; Licastro F
Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis.
Bennermo M; Held C; Hamsten A; Strandberg LE; Ericsson CG; Hansson LO; Tornvall P
J Intern Med; 2003 Sep; 254(3):244-50. PubMed ID: 12930233
[TBL] [Abstract][Full Text] [Related]
9. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors.
Lieb W; Pavlik R; Erdmann J; Mayer B; Holmer SR; Fischer M; Baessler A; Hengstenberg C; Loewel H; Doering A; Riegger GA; Schunkert H
Int J Cardiol; 2004 Nov; 97(2):205-12. PubMed ID: 15458685
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokines and myocardial viability in patients after acute myocardial infarction.
Kosmala W; Przewlocka-Kosmala M; Mazurek W
Int J Cardiol; 2005 Jun; 101(3):449-56. PubMed ID: 15907414
[TBL] [Abstract][Full Text] [Related]
11. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment.
Pietilä KO; Harmoinen AP; Jokiniitty J; Pasternack AI
Eur Heart J; 1996 Sep; 17(9):1345-9. PubMed ID: 8880019
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India.
Chakraborty B; Chowdhury D; Vishnoi G; Goswami B; Kishore J; Agarwal S
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):683-9. PubMed ID: 22410655
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction.
Vakili H; Ghaderian SM; Akbarzadeh Najar R; Tabatabaei Panah AS; Azargashb E
Coron Artery Dis; 2011 Aug; 22(5):299-305. PubMed ID: 21512395
[TBL] [Abstract][Full Text] [Related]
15. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS
Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein on admission as a predictor of in-hospital death in the elderly with acute myocardial infarction.
Gheno G; Libardoni M; Zeppellini R; Cucchini F
Cardiologia; 1999 Dec; 44(12):1023-8. PubMed ID: 10687251
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction.
Nauck M; Winkelmann BR; Hoffmann MM; Böhm BO; Wieland H; März W
J Mol Med (Berl); 2002 Aug; 80(8):507-13. PubMed ID: 12185451
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome.
Mälarstig A; Wallentin L; Siegbahn A
Thromb Res; 2007; 119(4):467-73. PubMed ID: 16782174
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
[TBL] [Abstract][Full Text] [Related]
20. The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.
Foussas SG; Zairis MN; Makrygiannis SS; Manousakis SJ; Anastassiadis FA; Apostolatos CS; Patsourakos NG; Glyptis MP; Papadopoulos JK; Xenos DC; Adamopoulou EN; Olympios CD; Argyrakis SK
Heart; 2007 Aug; 93(8):952-6. PubMed ID: 17344331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
